Trump pressed RFK Jr. to prioritize vaccine-autism research after advisers told him to drop it

President Trump personally demanded HHS Secretary Robert F. Kennedy Jr. make vaccine-autism research a top priority, weeks after White House political advisers had told Kennedy to do the opposite ahead of the midterms.

The directive came at a May lunch at a presidential golf course in northern Virginia, where Trump asked Kennedy why he wasn't doing more to probe a possible connection between childhood vaccines and autism, Raw Story reported, citing a Wall Street Journal investigation. Kennedy was "taken aback" by the request, the Journal reported, because he had spent the preceding weeks complying with guidance from White House political staff to tone down his public stance on vaccines.

The whiplash illustrates a tension at the center of the administration's health policy: Kennedy arrived at HHS as the most outspoken vaccine skeptic ever to hold the job, then received orders to quiet down for political reasons, and now faces a president who wants him to ramp back up, all while unnamed advisers second-guess his progress.

Kennedy followed orders, then got reversed

In the weeks before the May lunch, White House political advisers told Kennedy to pull back on what they called his anti-vaccine positions. Their concern was straightforward: Kennedy's views could alienate voters ahead of the midterm elections. Kennedy complied, reducing his public messaging on the issue.

Then Trump upended that approach over lunch. He told Kennedy that researching a vaccine-autism link should be a "priority," a direct reversal of what his own political team had communicated. The president didn't stop there.

By mid-June, Trump raised the issue again in an Oval Office meeting. People familiar with the conversation told the Wall Street Journal that Trump "vented to Kennedy that he wasn't doing enough." The Journal's sources described the vaccine question as "an ongoing point of tension between the two men."

People familiar with the president's thinking offered a blunter assessment:

"The president has made clear he thinks he has given Kennedy enough time and is disappointed the health secretary hasn't accomplished more in the past year and a half."

That year-and-a-half window suggests Trump has been measuring Kennedy's tenure from the start and finds the results lacking, though no specific benchmarks or deliverables were cited in the reporting.

Trump steers 'nearly every conversation' back to vaccines

The May lunch was not an isolated moment. Breitbart reported that Trump has been privately pressuring Kennedy to cut the number of childhood vaccines and update federal guidance, driven by concern over rising autism rates. The Journal noted that "the president steers nearly every conversation with his health secretary back to the issue," according to people familiar with the matter.

Kennedy himself has acknowledged the scope of the problem he was brought in to address. "The epidemic is real," he said of autism rates, according to the Breitbart report. Under his leadership, the CDC removed the coronavirus vaccine from the recommended immunization schedule for healthy children and healthy pregnant women, and the administration banned mercury-based preservatives in flu shots.

Those moves represent concrete policy shifts. But for a president who wants faster and broader action, they apparently haven't been enough. The pattern fits a broader willingness by Trump to push senior officials who he believes are not moving quickly enough on his priorities.

Kennedy already overhauled the vaccine advisory board

Kennedy has not been idle on vaccine policy. In June 2025, he removed all 17 Biden-appointed members of the CDC's Advisory Committee on Immunization Practices, the panel that shapes national vaccine recommendations. He replaced them with new appointees aligned with the administration's health agenda, framing the move as a step toward restoring public trust.

"Today we are prioritizing the restoration of public trust above any specific pro- or anti-vaccine agenda," Kennedy said at the time, National Review reported.

That overhaul drew criticism from Senator Bill Cassidy, a Louisiana Republican and medical doctor, who noted Kennedy had promised during his confirmation process not to interfere with the advisory committee. Cassidy warned that the panel could be "filled up with people who know nothing about vaccines except suspicion."

The advisory committee shake-up, the removal of COVID vaccines from the childhood schedule, and the mercury preservative ban add up to a substantial record of action on vaccine policy. Yet the Wall Street Journal's reporting makes clear that Trump views these steps as insufficient, and that Kennedy's continued tenure at HHS may depend on delivering more.

The administration has also faced legal obstacles on this front. A federal court blocked portions of Kennedy's vaccine policy overhaul, and the Trump administration appealed the ruling, signaling that the White House is committed to the policy direction even when courts push back.

Mixed signals leave Kennedy in a difficult position

The core problem for Kennedy is not just the scale of the task. It is the contradictory signals from within the White House itself. One set of advisers told him to go quiet on vaccines for political reasons. The president then told him to make the same issue his top priority. Both directives came within weeks of each other.

Kennedy complied with the first order, reducing his public messaging. He was then caught off guard by the second. No public response from Kennedy to Trump's May demand or the mid-June Oval Office meeting has been reported.

This kind of abrupt course correction is not unprecedented in the Trump administration. The president has shown a willingness to replace high-profile appointees when he believes they are not delivering results, and he has reversed personnel decisions in the health policy space before.

What remains unclear is what "progress" on vaccine-autism research would look like in practice, what specific studies, policy changes, or federal guidance updates would satisfy the president's expectations. The Journal's reporting identifies no concrete benchmarks, and no timeline for deliverables has been made public.

Also unresolved: whether the political advisers who told Kennedy to stand down on vaccines still hold that view, or whether Trump's personal intervention has settled the internal debate. If the advisers' midterm concerns were valid weeks ago, they haven't evaporated simply because the president changed direction.

Kennedy took the HHS job as the administration's most prominent voice on vaccine safety. He was told to be quieter. Now he's being told to be louder. The question isn't whether he can navigate the contradiction, it's whether anyone could.